Inizio announced a significant expansion of its Global Medical Information capabilities through Inizio Engage, introducing Connected Insights to help pharmaceutical and biotechnology companies transform Medical Information from a responsive support function into a strategic source of intelligence. Combining expanded Asia-Pacific expertise, enhanced global infrastructure, and AI-enabled innovation, the investment enables organizations to generate actionable insights from every scientific interaction while delivering consistent, high-quality Medical Information at global scale.1Why is this expansion happening now? As therapies become increasingly specialized and scientific engagement grows more complex, Medical Information teams are expected to do far more than answer inquiries. Designed to support organizations operating across global and regional markets, Inizio Engage delivers Medical Information programs in more than 20 languages, combining the simplicity of a single global partner with deep local expertise. Amy Van Sant, global president, medical affairs, Inizio Engage, added: "By combining scientific expertise with AI-enabled capabilities and global scale, we're helping clients unlock significantly more value from every interaction and redefine what's possible through Global Medical Information."